Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.64 |
| ▸ | FAAH | O00519 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | XBP1 | P17861 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.52 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.52 |
| ▸ | GSK3A | P49840 | 5/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9917644 | 0.87 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL15676692 | 0.87 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL1970948 | 0.87 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL7093769 | 0.86 | MGLL (0.62) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL8764931 | 0.85 | MGLL (0.67) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL14996147 | 0.83 | MGLL (0.68) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL17192614 | 0.83 | MGLL (0.68) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL13339471 | 0.83 | MGLL (0.67) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL13344076 | 0.82 | MGLL (0.71) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL407969 | 0.80 | MGLL (0.95) | MGLLFAAHALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 543 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092317-A1 | TETHERED AMPLIFICATION PRODUCTS IN CELLS AND TISSUES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-04-02 | — | — | US | claimed |
| US-12514937-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2026-01-06 | — | — | US | claimed |
| US-20250354056-A1 | POLYMER DOTS | BIO RAD LABORATORIES INC (US) | 2025-11-20 | — | — | US | claimed |
| WO-2025147760-A1 | PEPTIDES, HYDROGELS, PHOTOACTIVATABLE HYDROGEL PRECURSORS, METHODS OF PREPARATION AND DEVICES FOR DELIVERY THEREOF, AND METHODS OF TREATMENT THEREWITH | OTTAWA HEART INSTITUTE RESEARCH CORPORATION (CA) | 2025-07-17 | — | — | WO | claimed |
| US-12344780-B2 | Polymer dots | BIO-RAD LABORATORIES, INC. (US) | 2025-07-01 | — | — | US | claimed |
| CN-119258236-B | NK cell membrane modification-based multifunctional manganese-based hybrid nano platform and preparation method and application thereof | 广州贝奥吉因生物科技股份有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-20250145994-A1 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO CELLULAR SENESCENCE | UNIVERSITY OF SOUTH FLORIDA | 2025-05-08 | — | — | US | claimed |
| CN-119709715-A | Phenylalanine ammonia-lyase mutant with high activity and stability and application thereof | 鸿筠医学科技(北京)有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119391205-A | Zwitterionic near infrared fluorescent dye modified by PEG (polyethylene glycol) as well as preparation method and application thereof | 南京市云影生物科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119258236-A | NK cell membrane modification-based multifunctional manganese-based hybrid nano platform and preparation method and application thereof | 广州贝奥吉因生物科技股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| EP-4146665-A1 | SYSTEMS AND METHODS FOR TYROSINASE-MEDIATED SITE-SPECIFIC PROTEIN CONJUGATION | GENENTECH, INC. (US) | 2023-03-15 | — | — | EP | claimed |
| CN-111228219-B | Blank liposome taking ginsenoside Rg3 or analogue thereof as membrane material, preparation method and application thereof | 上海参素药物技术有限公司 | 2023-01-06 | — | — | CN | claimed |
| CN-115551875-A | Systems and methods for tyrosinase-mediated site-specific protein conjugation | 基因泰克公司 | 2022-12-30 | — | — | CN | claimed |
| CN-114920819-A | Recombinant human growth hormone mutant, polyethylene glycol derivative thereof, preparation method of polyethylene glycol derivative and pharmaceutical application of polyethylene glycol derivative | 修正生物医药（杭州）研究院有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-112717143-B | Biodegradable nano-carrier and targeting drug-loading system thereof | 洛兮医疗科技(杭州)有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-114806539-A | Surface biocompatibility modification method of semiconductor nanocrystal | 中国科学院化学研究所 | 2022-07-29 | — | — | CN | claimed |
| CN-114652848-A | PEG (polyethylene glycol) human serum albumin nano material, preparation method thereof and application thereof in tumor diagnosis and treatment | 山东大学齐鲁医院 | 2022-06-24 | — | — | CN | claimed |
| EP-4010400-A1 | POLYMER DOTS | Bio-Rad Laboratories, Inc. (US) | 2022-06-15 | — | — | EP | claimed |
| US-11319533-B2 | CRISPR nanocomplex for nonviral genome editing and method for preparing the same | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-05-03 | — | — | US | claimed |
| CN-114072446-A | Polymer dots | 生物辐射实验室股份有限公司 | 2022-02-18 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145994-A1 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO CELLULAR SENESCENCE | EXOSC9, EXOSC4, TP53 | MGLL 2971/4885FAAH 4358/4885ALDH1A1 4387/4885 |
| US-20260092317-A1 | TETHERED AMPLIFICATION PRODUCTS IN CELLS AND TISSUES | POLRMT, SSBP1, TRMT1L | MGLL 2693/4885FAAH 4252/4885ALDH1A1 3021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.